Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Submitted by
admin
on April 21, 2012 - 12:17pm
Source:
Seeking Alpha
News Tags:
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Headline:
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Do Not Allow Advertisers to Use My Personal information
